Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MEG.0000000000001811 http://scihub22266oqcxt.onion/10.1097/MEG.0000000000001811 32501876!7846254!32501876     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Gastroenterol+Hepatol 2021 ; 33 (3): 319-324 Nephropedia Template TP {{tp|p=32501876|t=2021. Implications of COVID-19 for the busy gastroenterologist |pdf=|usr=}}{{32501876}} gab.com Text Implications of COVID-19 for the busy gastroenterologist JO: Eur J Gastroenterol Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=32501876 #FOAvip Coronavirus disease 2019 (COVID-19) is an infection caused by a novel coronavirus (SARS-CoV-2) originated in China in December 2020 and declared pandemic by WHO. This coronavirus mainly spreads through the respiratory tract and enters cells through angiotensin-converting enzyme 2 (ACE2). The clinical symptoms of COVID-19 patients include fever, cough, and fatigue. Gastrointestinal symptoms (diarrhea, anorexia, and vomiting) may be present in 50% of patients and may be associated with worst prognosis. Other risk factors are older age, male gender, and underlying chronic diseases. Mitigation measures are essential to reduce the number of people infected. Hospitals are a place of increased SARS-CoV-2 exposure. This has implications in the organization of healthcare services and specifically endoscopy departments. Patients and healthcare workers safety must be optimized in this new reality. Comprehension of COVID-19 gastrointestinal manifestations and implications of SARS-CoV-2 in the management of patients with gastrointestinal diseases, under or not immunosuppressant therapies, is essential. In this review, we summarized the latest research progress and major societies recommendations regarding the implications of COVID-19 in gastroenterology, namely the adaptations that gastroenterology/endoscopy departments and professionals must do in order to optimize the provided assistance, as well as the implications that this infection will have, in particularly vulnerable patients such as those with chronic liver disease and inflammatory bowel disease under or not immunosuppressant therapies. Twit Text FOAVip Implications of COVID-19 for the busy gastroenterologist ????Eur J Gastroenterol Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=32501876 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32501876 #FOAvip English Wikipedia <ref>{{Cite pmid|32501876}}</ref> Implications of COVID-19 for the busy gastroenterologist #MMPMID32501876 Ferreira-Silva J; Peixoto A; Rodrigues-Pinto E; Macedo G Eur J Gastroenterol Hepatol 2021[Mar]; 33 (3): 319-324 PMID32501876show ga Coronavirus disease 2019 (COVID-19) is an infection caused by a novel coronavirus (SARS-CoV-2) originated in China in December 2020 and declared pandemic by WHO. This coronavirus mainly spreads through the respiratory tract and enters cells through angiotensin-converting enzyme 2 (ACE2). The clinical symptoms of COVID-19 patients include fever, cough, and fatigue. Gastrointestinal symptoms (diarrhea, anorexia, and vomiting) may be present in 50% of patients and may be associated with worst prognosis. Other risk factors are older age, male gender, and underlying chronic diseases. Mitigation measures are essential to reduce the number of people infected. Hospitals are a place of increased SARS-CoV-2 exposure. This has implications in the organization of healthcare services and specifically endoscopy departments. Patients and healthcare workers safety must be optimized in this new reality. Comprehension of COVID-19 gastrointestinal manifestations and implications of SARS-CoV-2 in the management of patients with gastrointestinal diseases, under or not immunosuppressant therapies, is essential. In this review, we summarized the latest research progress and major societies recommendations regarding the implications of COVID-19 in gastroenterology, namely the adaptations that gastroenterology/endoscopy departments and professionals must do in order to optimize the provided assistance, as well as the implications that this infection will have, in particularly vulnerable patients such as those with chronic liver disease and inflammatory bowel disease under or not immunosuppressant therapies. |*Endoscopy, Gastrointestinal/adverse effects[MESH] |*Gastroenterologists[MESH] |*Infection Control[MESH] |*Practice Patterns, Physicians'[MESH] |COVID-19/immunology/*prevention & control/transmission[MESH] |Clinical Decision-Making[MESH] |Decision Support Techniques[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Infectious Disease Transmission, Patient-to-Professional/*prevention & control[MESH] |Infectious Disease Transmission, Professional-to-Patient/*prevention & control[MESH] |Liver Diseases/diagnosis/immunology/*therapy[MESH] |Occupational Health[MESH] |Patient Safety[MESH] |Risk Assessment[MESH]Implications of COVID-19 for the busy gastroenterologist (epmc).pdf DeepDyve Pubget Overpricing